Vilin Bio Med Limited (NSE:VILINBIO)

Vilin Bio Med Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	626	285	265	-	-	-
Market Cap Growth	113.57%	7.37%	-	-	-	-
Enterprise Value	629	297	255	-	-	-
Last Close Price	44.85	20.40	19.00	-	-	-
PE Ratio	249.48	127.33	163.21	-	-	-
PS Ratio	3.13	1.92	1.68	-	-	-
PB Ratio	2.70	1.23	1.16	-	-	-
P/TBV Ratio	2.70	1.23	1.16	-	-	-
P/OCF Ratio	-	130.84	-	-	-	-
EV/Sales Ratio	3.15	2.00	1.61	-	-	-
EV/EBITDA Ratio	89.70	37.70	31.22	-	-	-
EV/EBIT Ratio	105.40	43.47	37.14	-	-	-
Debt / Equity Ratio	0.02	0.11	0.30	0.46	0.72	0.75
Debt / EBITDA Ratio	0.65	3.27	8.36	1.90	6.88	6.41
Debt / FCF Ratio	-	-	-	-	25.39	-
Net Debt / Equity Ratio	0.02	0.11	0.03	0.46	0.71	0.74
Net Debt / EBITDA Ratio	0.52	3.20	0.96	1.89	6.83	6.36
Net Debt / FCF Ratio	-0.21	-1.85	-0.10	-2.90	25.21	-5.46
Asset Turnover	0.69	0.49	0.63	0.79	0.82	0.84
Inventory Turnover	3.65	3.04	4.88	4.59	4.13	4.33
Quick Ratio	3.33	1.39	1.26	0.87	1.63	1.58
Current Ratio	7.78	2.75	2.01	1.24	2.22	2.19
Return on Equity (ROE)	1.09%	0.97%	0.97%	13.78%	0.46%	1.66%
Return on Assets (ROA)	1.28%	1.42%	1.71%	9.72%	2.51%	2.70%
Return on Invested Capital (ROIC)	1.84%	2.03%	2.53%	12.03%	3.25%	3.70%
Return on Capital Employed (ROCE)	2.60%	2.90%	3.00%	21.70%	6.70%	7.20%
Earnings Yield	0.40%	0.78%	0.61%	-	-	-
FCF Yield	-2.80%	-4.77%	-28.00%	-	-	-
Buyback Yield / Dilution	-0.47%	-	-40.20%	-20.61%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.